Analyst Price Target is $20.60
▲ +98.08% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Nyxoah in the last 3 months. The average price target is $20.60, with a high forecast of $27.00 and a low forecast of $14.00. The average price target represents a 98.08% upside from the last price of $10.40.
Current Consensus is
Moderate Buy
The current consensus among 6 investment analysts is to moderate buy stock in Nyxoah. This Moderate Buy consensus rating has held steady for over two years.
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Read More